MIRA Pharmaceuticals Inc. (NASDAQ: MIRA)
$0.75
+0.0100 ( +1.35% ) 1.4M
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Market Data
Open
$0.75
Previous close
$0.74
Volume
1.4M
Market cap
$11.97M
Day range
$0.64 - $0.83
52 week range
$0.51 - $7.98
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 27, 2023 |
8-k | 8K-related | 12 | Dec 01, 2023 |
8-k | 8K-related | 17 | Nov 20, 2023 |
3 | Insider transactions | 2 | Nov 20, 2023 |
4 | Insider transactions | 1 | Nov 17, 2023 |
10-q | Quarterly Reports | 52 | Nov 13, 2023 |
3 | Insider transactions | 2 | Nov 03, 2023 |
8-k | 8K-related | 12 | Oct 25, 2023 |
3 | Insider transactions | 2 | Oct 12, 2023 |
10-q | Quarterly Reports | 55 | Sep 15, 2023 |